Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
- Status
- COMPLETED
- Phase
- PHASE2
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
- Status
- TERMINATED
- Phase
- PHASE3
GEM-CLARIDEX: Ld vs BiRd
- Status
- UNKNOWN
- Phase
- PHASE3
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Maintenance in Plasma Cell Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide for Adult Histiocyte Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension
- Status
- COMPLETED
- Phase
- PHASE1